Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer
Open Access
- 6 October 2021
- journal article
- research article
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 9 (10) , e003371
Abstract
Background Triple-negative breast cancers (TNBCs), especially those non-immune-inflamed tumors, have a poor prognosis and limited therapies. Human leukocyte antigen (HLA)-I not only contributes to antitumor immune response and the phenotype of the tumor microenvironment, but also is a negative predictor of outcomes after immunotherapy. However, the importance of HLA functional status in TNBCs remains poorly understood. Methods Using the largest original multiomics datasets on TNBCs, we systematically characterized the HLA-Ⅰ status of TNBCs from the perspective of HLA-Ⅰ homogeneity and loss of heterozygosity (LOH). The prognostic significance of HLA-I status was measured. To explain the potential mechanism of prognostic value in HLA-Ⅰ status, the mutational signature, copy number alteration, neoantigen and intratumoral heterogeneity were measured. Furthermore, the correlation between HLA-Ⅰ functional status and the tumor immune microenvironment was analyzed. Results LOH and homogeneity in HLA-I accounted for 18% and 21% of TNBCs, respectively. HLA-I LOH instead of HLA-I homogeneity was an independent prognostic biomarker in TNBCs. In particular, for patients with non-immune-inflamed tumors, HLA-I LOH indicated a worse prognosis than HLA-I non-LOH. Furthermore, integrated genomic and transcriptomic analysis showed that HLA-I LOH was accompanied by upregulated scores of mutational signature 3 and homologous recombination deficiency scores, which implied the failure of DNA double-strand break repair. Moreover, HLA-I LOH had higher mutation and neoantigen loads and more subclones than HLA-I non-LOH. These results indicated that although HLA-I LOH tumors with failure of DNA double-strand break repair were prone to produce neoantigens, their limited capacity for antigen presentation finally contributed to poor immune selection pressure. Conclusion Our study illustrates the genomic landscape of HLA-I functional status and stresses the prognostic significance of HLA-I LOH in TNBCs. For “cold” tumors in TNBCs, HLA-I LOH indicated a worse prognosis than HLA-I non-LOH.Keywords
Funding Information
- Shanghai three year action plan for Traditional Chinese Medicine (ZY(2018-2020)-CCCX-2005-04)
- Shanghai Key Laboratory of Breast Cancer (12DZ2260100)
- National Key Research and Development Project of China (2020YFA0112304)
- Shanghai Rising-Star Program (20YF1408600)
- National Natural Science Foundation of China (81902684, 82002792, 82072922)
This publication has 44 references indexed in Scilit:
- Association of BRCA1/2defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypesBreast Cancer Research, 2014
- PyClone: statistical inference of clonal population structure in cancerNature Methods, 2014
- HLA Class I Alleles Are Associated with Peptide-Binding Repertoires of Different Size, Affinity, and ImmunogenicityThe Journal of Immunology, 2013
- LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult GlioblastomaClinical Cancer Research, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Allele-specific copy number analysis of tumorsProceedings of the National Academy of Sciences, 2010
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- MHC heterozygosity confers a selective advantage against multiple-strain infectionsProceedings of the National Academy of Sciences, 2002
- NATURAL SELECTION AT MAJOR HISTOCOMPATIBILITY COMPLEX LOCI OF VERTEBRATESAnnual Review of Genetics, 1998